Read this before buying Ramsay Health Care shares for its dividend

Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX:RHC ) shares go ex-dividend on Wednesday March 6, 2019. Here's what you need to know.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) share price fell 1.32% on the ASX today to close at $63.03.

If you've been thinking of buying shares in the global hospital group for its growing, fully franked divided, there are a few things you need to know today.

The first is that shares will go ex-dividend on Wednesday, March 6, 2019.  The 'ex-date' is when the shares start selling without the value of its next dividend payment so an investor needs to own the shares before the ex-date to receive the dividend. The dividend will then be paid on Friday, March 29, 2019.

a woman

What is Ramsay Health Care's dividend yield?

At its recent half-year results, Ramsay declared a dividend of 60 cents per share for the half year. This was up 4.3% on the same period in 2018 and at the current share price of $63 per share the company offers a trailing dividend yield of 2.3%, fully franked.

Is the dividend sustainable going forward?

This is a great question to ask before buying any company for its dividend.

At the company's half-year update last week Ramsay presented Net profit after tax (NPAT) of $274 million for the six months to 31 December 2018, up 1.1% on the same period in 2017.

Pleasingly revenue lifted 16% and cash flows from operations lifted 6.5% which is a positive sign for sustaining dividends.

Ramsay has a strong history of earnings and dividend growth and looking forward the group is expecting to achieve its guidance of 'Core' earnings per share (EPS) growth of up to 2% for the full financial year.

Foolish takeaway

I think Ramsay Health Care will be a clear beneficiary of the long-term trend of increasing healthcare expenditure and although its current yield of 2.3% is not earth-shattering, the long-term prospects for increasing distributions to investors would be worth short-listing to my dividend watch-list.

However, there are also several other companies going ex-dividend on 06 March to consider, including:

  • FlexiGroup Limited (ASX: FXL)
  • Event Hospitality and Entertainment Ltd (ASX: EVT)
  • Hansen Technologies Limited (ASX: HSN)

Regan Pearson has no position in any of the stocks mentioned. You can follow him on Twitter @Regan_Invests. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Hansen Technologies. The Motley Fool Australia has recommended FlexiGroup Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »